ArticleRMD open2017

Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.

René-Marc Flipo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.